What is Reta GLP-1?
Reta GLP-1 (clinically known as Retatrutide) is the world’s first “Triple-Hormone-Receptor Agonist.” While previous generations of weight loss medications targeted one or two pathways, Reta GLP-1 targets three: GLP-1, GIP, and Glucagon. At Balanced Medical Solutions, Reta GLP-1 is considered the “Apex” of medical weight loss. By adding the Glucagon receptor to the formula, it doesn’t just suppress your appetite—it actively increases your body’s metabolic “burn” rate and targets liver fat more aggressively than any medication before it.
Common Uses of Reta GLP-1 for Balanced Medical Solutions’ San Francisco and East Bay Area Patients:
-
Unprecedented Weight Loss Results: Clinical trials (Phase 3) have shown that patients taking Reta GLP-1 lost an average of nearly 30% of their total body weight over 68 weeks. This significantly outperforms Semaglutide (15%) and Tirzepatide (22.5%).
-
The “Metabolic Boost” (The Glucagon Edge): Unlike other GLP-1s that mainly slow digestion, Reta GLP-1 stimulates the glucagon receptor. This signals the body to increase energy expenditure (thermogenesis) and break down fat cells for fuel, helping to prevent the “metabolic slowdown” that often occurs during dieting.
-
Aggressive Liver Fat Reduction: Reta GLP-1 is uniquely powerful for patients with Fatty Liver Disease (MASLD/MASH). Because the liver is rich in glucagon receptors, this medication can reduce liver fat by up to 80%, essentially “cleaning out” the organ for better overall metabolic health.
-
Quietening “Food Noise”: By acting on the hypothalamus and brainstem, Reta GLP-1 provides a profound sense of satiety. Patients describe a total disappearance of cravings and a much easier time sticking to a high-protein, healthy diet.
-
Relief from Joint Pain: Recent 2025 data shows that the massive weight reduction from Reta GLP-1 provides “substantial” relief for Knee Osteoarthritis, significantly improving mobility for active East Bay residents.
-
Cardiovascular & Kidney Protection: Beyond weight, it has been shown to lower systolic blood pressure (by up to 14 mmHg) and improve inflammatory markers like C-reactive protein (CRP), protecting the heart and kidneys.